Literature DB >> 2271341

Excess purine degradation caused by an imbalance in the supply of adenosine triphosphate in patients with congestive heart failure.

I Hisatome1, R Ishiko, H Miyakoda, M Saito, H Kitamura, T Kinugawa, M Kobayashi, H Kotake, H Mashiba, R Sato.   

Abstract

To evaluate purine degradation in patients with congestive heart failure concentrations of serum hypoxanthine, lactate, and noradrenaline were measured before and after submaximal treadmill exercise in 12 patients with chronic congestive heart failure and nine healthy volunteers. In four patients the concentration of hypoxanthine was significantly higher than in the controls or in the remaining eight patients with congestive heart failure. Venous lactate and noradrenaline in the four patients with high concentrations of hypoxanthine were also significantly higher than those in the eight patients with normal concentrations of hypoxanthine. Patients who responded normally were also more likely to have been treated with vasodilators and angiotensin converting enzyme inhibitors. Exercise induced arrhythmias were more common in the patients with high concentrations of hypoxanthine. These results suggest that the excess purine degradation in patients with congestive heart failure might be the result of a "relative" disturbance in the supply of adenosine triphosphate caused by the shift of cellular metabolism from aerobic glycolysis to anaerobic glycolysis during submaximal exercise and that hypoxanthine (a substrate for xanthine oxidase and a source of free radicals) was increased after submaximal exercise in some patients with congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2271341      PMCID: PMC1224810          DOI: 10.1136/hrt.64.6.359

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  7 in total

1.  Excess purine degradation in skeletal muscle with hyperthyroidism.

Authors:  I Hisatome; R Ishiko; T Takeuchi; M Kobayashi; Y Fujimoto; J Hasegawa; H Kotake; H Mashiba
Journal:  Muscle Nerve       Date:  1990-06       Impact factor: 3.217

2.  Hyperuricemia: a marker for cell energy crisis.

Authors:  I H Fox; T D Palella; W N Kelley
Journal:  N Engl J Med       Date:  1987-07-09       Impact factor: 91.245

3.  Evidence for adenosine triphosphate degradation in critically-ill patients.

Authors:  C M Grum; R H Simon; D R Dantzker; I H Fox
Journal:  Chest       Date:  1985-11       Impact factor: 9.410

4.  Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.

Authors:  I Mineo; N Kono; N Hara; T Shimizu; Y Yamada; M Kawachi; H Kiyokawa; Y L Wang; S Tarui
Journal:  N Engl J Med       Date:  1987-07-09       Impact factor: 91.245

5.  Purine metabolism during strenuous muscular exercise in man.

Authors:  J R Sutton; C J Toews; G R Ward; I H Fox
Journal:  Metabolism       Date:  1980-03       Impact factor: 8.694

6.  Plasma hypoxanthine and exercise.

Authors:  L H Ketai; R H Simon; J W Kreit; C M Grum
Journal:  Am Rev Respir Dis       Date:  1987-07

7.  Determinants of coronary sinus noradrenaline in patients with ischaemic heart disease: coronary sinus catecholamine concentration in relation to arterial catecholamine concentration, pulmonary artery oxygen saturation and left ventricular end-diastolic pressure.

Authors:  J F Hansen; N J Christensen; B Hesse
Journal:  Cardiovasc Res       Date:  1978-07       Impact factor: 10.787

  7 in total
  4 in total

1.  Angiotensin AT1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine.

Authors:  G A Rongen; S C Brooks; S i Ando; B L Abramson; J S Floras
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

2.  Metabolomics assessment reveals oxidative stress and altered energy production in the heart after ischemic acute kidney injury in mice.

Authors:  Benjamin M Fox; Hyo-Wook Gil; Lara Kirkbride-Romeo; Rushita A Bagchi; Sara A Wennersten; Korey R Haefner; Nataliya I Skrypnyk; Carolyn N Brown; Danielle E Soranno; Katja M Gist; Benjamin R Griffin; Anna Jovanovich; Julie A Reisz; Matthew J Wither; Angelo D'Alessandro; Charles L Edelstein; Nathan Clendenen; Timothy A McKinsey; Christopher Altmann; Sarah Faubel
Journal:  Kidney Int       Date:  2019-01-30       Impact factor: 10.612

3.  Core functional nodes and sex-specific pathways in human ischaemic and dilated cardiomyopathy.

Authors:  Mengbo Li; Benjamin L Parker; Evangeline Pearson; Benjamin Hunter; Jacob Cao; Yen Chin Koay; Oneka Guneratne; David E James; Jean Yang; Sean Lal; John F O'Sullivan
Journal:  Nat Commun       Date:  2020-06-02       Impact factor: 14.919

4.  Impaired Myocardial Energetics Causes Mechanical Dysfunction in Decompensated Failing Hearts.

Authors:  Rachel Lopez; Bahador Marzban; Xin Gao; Ellen Lauinger; Françoise Van den Bergh; Steven E Whitesall; Kimber Converso-Baran; Charles F Burant; Daniel E Michele; Daniel A Beard
Journal:  Function (Oxf)       Date:  2020-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.